VON WILLEBRAND DISEASE (VWD), TYPE 2
Clinical trials for VON WILLEBRAND DISEASE (VWD), TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD), TYPE 2 trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bleeding disorder: experimental drug HMB-002 enters human testing
Disease control Recruiting nowThis study tests a new medicine, HMB-002, in 108 adults with von Willebrand disease (types 1 and 2). The goal is to check if the drug is safe, how the body processes it, and whether it helps control bleeding. Participants will receive either one or several doses of the drug, and …
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New drug hopes to stop bleeding in rare blood disorder
Disease control Recruiting nowThis study tests a new drug called BT200 in 4-6 adults with type 2B von Willebrand disease who have low platelets and a history of bleeding. The drug aims to raise levels of a key clotting protein and platelets, which should reduce bleeding episodes. Participants receive both BT2…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New study aims to map Real-World bleeding in von willebrand disease
Knowledge-focused Recruiting nowThis study is gathering information about bleeding episodes, quality of life, and treatment use in 200 people with von Willebrand disease (VWD). Participants will report their bleeding events and complete surveys over time. The data will help researchers understand the daily impa…
Matched conditions: VON WILLEBRAND DISEASE (VWD), TYPE 2
Sponsor: Hemab ApS • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC